Dr C Glenn Begley MB, BS, PhD, FRACP, FRCPA, FRCPath, FAHMS
Dr Begley currently advises several biotechnology companies, academic groups and served as Chief Scientific Officer at two small biotechnology companies, From 2002-2012, he was Vice-President and Global Head of Hematology/Oncology Research at Amgen, responsible for building, directing and integrating Amgen’s 5 research sites. During this time he became interested in the issue of research integrity and scientific reproducibility. Before joining Amgen he had over 20 years of clinical experience in medical oncology and hematology.
He is Board Certified in Australia as a Medical Oncologist and Hematologist, has a PhD in cellular and molecular biology.
